Benralizumab for PDGFRA-Negative Hypereosinophilic Syndrome.
N Engl J Med
; 380(14): 1336-1346, 2019 04 04.
Article
in En
| MEDLINE
| ID: mdl-30943337
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hypereosinophilic Syndrome
/
Interleukin-5 Receptor alpha Subunit
/
Antibodies, Monoclonal, Humanized
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
N Engl J Med
Year:
2019
Document type:
Article
Country of publication:
United States